Abstract

During pregnancy, vaginal colonization by Candida spp is common. Some studies suggest an association between asymptomatic vaginal Candida colonization and adverse pregnancy outcomes, but the evidence is inconsistent. This review aimed to systematically review the association between asymptomatic vaginal colonization by Candida spp and adverse pregnancy outcomes, including preterm birth. We searched Ovid MEDLINE, Ovid Embase, and the Cochrane Central Register of Controlled Trials from inception to May 6, 2020 for published studies on vaginal Candida/yeast and pregnancy outcomes. Cohort studies, case-control studies, and randomized controlled trials that included pregnant women who were tested for asymptomatic vaginal Candida colonization and reported on adverse pregnancy outcomes were eligible. Two reviewers independently selected and extracted the data. Critical appraisal was performed using the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies and the revised Cochrane risk-of-bias tool for randomized controlled trials. We found no significant difference in preterm birth rate between Candida-positive and Candida-negative women (odds ratio, 1.10; 95% confidence interval, 0.99-1.22; I2, 0%) in 15 studies among 33,321 women for either spontaneous preterm birth only (odds ratio, 1.13, 95% confidence interval, 0.97-1.31; I2, 0%) or all preterm birth (odds ratio, 1.04; 95% confidence interval, 0.79-1.35; I2, 21%). Subgroup analyses for a treatment strategy including only studies reporting on spontaneous preterm birth did not reveal any statistically significant associations either, although the odds ratio was increased for the untreated Candida-positive women (odds ratio, 1.28; 95% confidence interval, 0.90-1.81; I2, 13%) in 3 studies among 5175 women. Asymptomatic vaginal Candida colonization was not associated with small for gestational age, perinatal mortality, or any other adverse pregnancy outcome. Asymptomatic vaginal Candida colonization is not associated with preterm birth and other adverse pregnancy outcomes. Previous studies reported that treatment of this microorganism reduces preterm birth rate. Our results suggest that this effect is unlikely to rely on treatment of vaginal Candida.

Highlights

  • Adverse pregnancy outcomes such as preterm birth (PTB) and fetal growth restriction are major obstetrical and public health problems

  • We found no significant difference in preterm birth rate between Candidapositive and Candida-negative women in 15 studies among 33,321 women for either spontaneous preterm birth only or all preterm birth

  • Key findings In a meta-analysis including 34,730 women, we found no association between asymptomatic vaginal Candida colonization and adverse pregnancy outcomes

Read more

Summary

Introduction

Adverse pregnancy outcomes such as preterm birth (PTB) and fetal growth restriction are major obstetrical and public health problems. Perinatal mortality accounts for >5 million deaths every year, of which approximately 2 million occur in the early neonatal period.1e3 There is accumulating evidence that genital tract infection or inflammation and placental malperfusion syndromes could underlie both PTB and fetal growth restriction. Genital tract infection has been implicated as a risk factor for PTB and fetal growth restriction.4e11 Preterm prelabor rupture. From the Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development Institute (Dr Schuster, Ms de Jonghe, and Dr Painter) and Medical Library (Dr Limpens), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Department of Medical Microbiology and Infection Control, Amsterdam institute for Infection and Immunity, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands (Dr Schuster); and inBiome, Amsterdam, Netherlands (Dr Budding).

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.